BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23273604)

  • 1. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
    Schweighofer CD; Coombes KR; Majewski T; Barron LL; Lerner S; Sargent RL; O'Brien S; Ferrajoli A; Wierda WG; Czerniak BA; Medeiros LJ; Keating MJ; Abruzzo LV
    J Mol Diagn; 2013 Mar; 15(2):196-209. PubMed ID: 23273604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
    Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
    Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Peres E; Kujawski L; Talpaz M; Kaminski M; Li C; Shedden K; Malek SN
    Blood; 2011 Sep; 118(11):3051-61. PubMed ID: 21795749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study.
    Bigoni R; Cuneo A; Roberti MG; Bardi A; Rigolin GM; Piva N; Scapoli G; Spanedda R; Negrini M; Bullrich F; Veronese ML; Croce CM; Castoldi G
    Leukemia; 1997 Nov; 11(11):1933-40. PubMed ID: 9369429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
    Edelmann J; Holzmann K; Miller F; Winkler D; Bühler A; Zenz T; Bullinger L; Kühn MW; Gerhardinger A; Bloehdorn J; Radtke I; Su X; Ma J; Pounds S; Hallek M; Lichter P; Korbel J; Busch R; Mertens D; Downing JR; Stilgenbauer S; Döhner H
    Blood; 2012 Dec; 120(24):4783-94. PubMed ID: 23047824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.
    Salaverria I; Martín-Garcia D; López C; Clot G; García-Aragonés M; Navarro A; Delgado J; Baumann T; Pinyol M; Martin-Guerrero I; Carrió A; Costa D; Queirós AC; Jayne S; Aymerich M; Villamor N; Colomer D; González M; López-Guillermo A; Campo E; Dyer MJ; Siebert R; Armengol L; Beà S
    Genes Chromosomes Cancer; 2015 Nov; 54(11):668-80. PubMed ID: 26305789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic features of B-cell chronic lymphocytic leukemia.
    Stilgenbauer S; Lichter P; Döhner H
    Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2011 Nov; 17(21):6778-90. PubMed ID: 21890456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.
    Döhner H; Stilgenbauer S; James MR; Benner A; Weilguni T; Bentz M; Fischer K; Hunstein W; Lichter P
    Blood; 1997 Apr; 89(7):2516-22. PubMed ID: 9116297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia.
    Sellmann L; Scholtysik R; de Beer D; Eisele L; Klein-Hitpass L; Nückel H; Dührsen U; Dürig J; Röth A; Baerlocher GM
    Leuk Lymphoma; 2016; 57(3):590-5. PubMed ID: 26457386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
    Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
    J Mol Med (Berl); 1999 Feb; 77(2):266-81. PubMed ID: 10023780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
    Mian M; Rinaldi A; Mensah AA; Rossi D; Ladetto M; Forconi F; Marasca R; Uhr M; Stussi G; Kwee I; Cavalli F; Gaidano G; Zucca E; Bertoni F
    Ann Oncol; 2013 May; 24(5):1378-84. PubMed ID: 23372049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.
    Laurie CC; Laurie CA; Smoley SA; Carlson EE; Flinn I; Fridley BL; Greisman HA; Gribben JG; Jelinek DF; Nelson SC; Paietta E; Schaid D; Sun Z; Tallman MS; Weinshilboum R; Kay NE; Shanafelt TD
    Cancer Genet; 2014; 207(1-2):19-30. PubMed ID: 24613276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.
    Houldsworth J; Guttapalli A; Thodima V; Yan XJ; Mendiratta G; Zielonka T; Nanjangud G; Chen W; Patil S; Mato A; Brown JR; Rai K; Chiorazzi N; Chaganti RS
    Leuk Lymphoma; 2014 Apr; 55(4):920-8. PubMed ID: 24047479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
    Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
    Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
    Haslinger C; Schweifer N; Stilgenbauer S; Döhner H; Lichter P; Kraut N; Stratowa C; Abseher R
    J Clin Oncol; 2004 Oct; 22(19):3937-49. PubMed ID: 15459216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.